SA hits nail on the head with choice of vaccine


SA hits nail on the head with choice of vaccine

Oxford-AstraZeneca will be easier and cheaper to roll out in SA than many of the top contenders

Senior features writer

When health minister Zweli Mkhize announced on Thursday that the first Covid-19 vaccine SA will get is the Oxford-AstraZeneca vaccine, it was an obvious first choice from the top contenders.

Most importantly, the science shows it works (70.4% efficacy) and it is safe. No severe side effects have been reported in ongoing clinical trials.

Half of the nearly 24,000 participants enrolled in the four randomised controlled trials taking place in Brazil, SA and the UK, from April to November 2020, have already got the vaccine...

This article is free to read if you register or sign in.

Sunday Times Daily

If you have already registered or subscribed, please sign in to continue.

Questions or problems?
Email or call 0860 52 52 00.